S.2443: Advancing Standards in Regenerative Medicine Act

About This Bill

  • This bill was introduced in the 114th Congress
  • This bill is primarily about health
  • Introduced Jan. 12, 2016
  • Latest Major Action Jan. 12, 2016

Bill Summary

Advancing Standards in Regenerative Medicine Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with S.2443.

Bill Actions

Date Description
Jan. 12, 2016
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan. 12, 2016

Introduced in the Senate by Tammy Baldwin (D-Wis.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page